Prone Positioning for Lung Transplant Outcomes
(P-POD Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores a new method to improve the condition of donated lungs for transplant by placing brain-dead donors on their stomachs (prone position) instead of their backs (supine position) during mechanical ventilation. The researchers aim to determine if this position helps maintain healthier lungs, potentially increasing the number of lungs available for life-saving transplants for people with lung disease. Suitable candidates for this trial are individuals declared brain-dead who have consented to organ donation, without open wounds on the front of their body or certain infections or cancers. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could enhance lung transplant success rates.
Will I have to stop taking my current medications?
The trial protocol does not specify whether participants must stop taking their current medications.
What prior data suggests that prone positioning is safe for lung transplant outcomes?
Research has shown that lying on the stomach, known as prone positioning, is generally safe. This position often aids people with breathing problems, such as those with acute respiratory distress syndrome (ARDS). Studies have also found that it can improve oxygen levels and reduce lung pressure in lung transplant patients.
However, some risks exist. One study found that while some patients could swallow safely in this position, others experienced issues like food or liquid entering the windpipe. Despite these concerns, prone positioning remains a safe and effective method to support better lung function in transplant situations. This approach could help make more donor lungs suitable for transplant.12345Why are researchers excited about this trial?
Researchers are excited about prone positioning for lung transplant patients because it could improve outcomes by optimizing lung function. Unlike the traditional supine position, prone positioning can enhance oxygenation and reduce ventilator-induced lung injury by distributing ventilation more evenly across the lungs. This method leverages gravity to help clear secretions and improve blood flow, potentially leading to better recovery and fewer complications post-transplant. Researchers hope to find out if these benefits can lead to significant improvements in patient outcomes compared to the standard supine positioning.
What evidence suggests that prone positioning is effective for improving lung transplant outcomes?
Research has shown that lying patients on their stomachs, known as prone positioning, improves lung function and oxygen levels after lung transplants. In this trial, participants will receive either protocolized protective mechanical ventilation in the prone position or in the supine position. Studies have found that the prone position allows the lungs to expand more easily, reducing breathing problems. In patients with severe lung issues like acute respiratory distress syndrome (ARDS), prone positioning has been linked to better survival rates and fewer complications. These findings suggest that using prone positioning in brain-dead lung donors might make more lungs suitable for transplant, potentially increasing the number of successful lung transplants.14567
Are You a Good Fit for This Trial?
This trial is for brain-dead individuals who are potential lung donors. It aims to see if laying them on their stomachs (prone position) instead of their backs can improve the quality of lungs for transplant.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Donors are positioned in either prone or supine position and undergo protocolized protective mechanical ventilation
Follow-up
Participants are monitored for protocol adherence and donor lung function outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Prone Positioning
Find a Clinic Near You
Who Is Running the Clinical Trial?
Lorenzo delSorbo
Lead Sponsor